Surgical management of a cat with hepatic arterioportal fistula

A Phillips1, E R Kulendra1, R Lam1

  • 1Department of Clinical Science and Service, The Royal Veterinary College, Hatfield, Hertfordshire, AL9 7TA, UK.

Insights

A cat with stunted growth and gastrointestinal issues was treated for a rare hepatic arterioportal fistula. Surgical repair led to full recovery, marking a first for this feline condition.

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Surgical Management

Background:

  • Feline hepatic arterioportal fistula is a rare vascular anomaly.
  • Congenital or acquired fistulas can lead to significant cardiovascular compromise.

Observation:

  • A 9-month-old cat presented with stunted growth, chronic gastrointestinal signs, tachypnea, heart murmur, and abdominal bruit.
  • Echocardiography indicated volume overload in all cardiac chambers.
  • CT angiography revealed an abnormal communication between hepatic arteries and the portal vein, alongside multiple acquired shunts.

Findings:

  • Successful surgical ligation of the abnormal vascular communication was performed.
  • Post-operative echocardiography showed improved cardiac parameters.
  • The cat remained clinically normal for 39 months following the intervention.

Implications:

  • This case demonstrates the first successful surgical management of a feline hepatic arterioportal fistula.
  • Surgical intervention can effectively resolve cardiovascular abnormalities associated with this condition in cats.
  • This highlights a potential treatment option for similar complex vascular anomalies in veterinary patients.

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
560
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
639
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
953
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
250